Search Results 71-80 of 16740 for CLL

  1. Study to Evaluate Safety and Preliminary Efficacy of MOR208 With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (COSMOS) - Mayo Clinic

    About this study. This is a two-cohort, multicenter, open-label study of MOR00208 combined with idelalisib or venetoclax in adult patients with R/R CLL or ...

  2. Household Controls for Clinical and Epidemiological Studies in Lymphoma and Chronic Lymphocytic Leukemia

    ... Chronic Lymphocytic Leukemia (CLL) with controls from a normal household and age-matched population. Participation eligibility. Participant eligibility ...

  3. A Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate oral LOXO-305 in patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin ...

  4. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or ...

  5. Clinical trials - Oncology (Medical)

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  6. Clinical trials - Oncology (Medical)

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...

  7. Family Study of Monoclonal B-Cell Lymphocytosis (MBL) - Mayo Clinic

    Given that family members of CLL patients are known to have an increased risk of CLL (on the order of 8-fold), and they have a higher prevalence of MBL than ...

  8. A Study to Evaluate Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    Giving ibrutinib and obinutuzumab with venetoclax may work better at treating chronic lymphocytic leukemia. Participation eligibility. Participant eligibility ...

  9. A Study to Compare ACP-196 and Obinutuzumab with Chlorambucil, or ACP-19 alone, with Obinutuzumab and Chlorambucil, for Patients with Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  10. Mayo Clinic Biobank - Cancer

    Chronic lymphocytic leukemia. Asish K. Ghosh, Ph.D., is researching the relationship of microvesicles to chronic lymphocytic leukemia (CLL) development.